German supplementary insurers (Zusatzversicherungen) are quietly restructuring their outbound referral policies. After years of informal tolerance, several major players are moving toward formal narrow-network arrangements with international providers — particularly for second opinions in oncology, orthopedics, and complex cardiac cases.
What is changing
Three trends are converging. First, German statutory insurance (GKV) waiting lists have lengthened post-pandemic, pushing more patients toward supplementary cover for faster access. Second, supplementary insurers are under margin pressure and looking for cost-effective alternatives to domestic specialist fees. Third, EU cross-border healthcare directive enforcement has matured, giving insurers clearer legal frameworks for international referrals.
What this means for exhibitors
Providers who can demonstrate formal insurer relationships — or credible pathways to them — will command significantly higher match scores in our AI system. The key signals insurers look for: JCI or ISO 15189 accreditation, German-language patient coordination capacity, and documented outcome data.
Booth narrative implications
If your booth messaging leads with price or geography, you are speaking to the wrong buyer in the German market. The conversation that converts in the DACH corridor is about clinical equivalence, liability clarity, and follow-up continuity. Reframe your pitch around the insurer's risk management problem, not the patient's cost saving.
At Kazel Medica Dortmund, we will host a dedicated insurer roundtable on Day 1 where providers can engage directly with supplementary plan case managers. This is where relationships that become formal referral agreements begin.
